{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:53:10Z","timestamp":1794408790955,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":32,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642812514","type":"print"},{"value":"9783642812491","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1978]]},"DOI":"10.1007\/978-3-642-81249-1_23","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T04:54:21Z","timestamp":1326689661000},"page":"188-196","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary Results of Chemoradiotherapy Followed (or Not) by Active Immunotherapy of Stage III and IV Lymphosarcoma and Reticulosarcoma: Correlation of the Results with WHO Categorization"],"prefix":"10.1007","author":[{"given":"J. L.","family":"Misset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Math\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tubiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Caillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. De","family":"Vassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pouillart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schwarzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Machover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Musset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"23_CR1","first-page":"60","volume-title":"Abstracts of the 16th International Congress of Haematol., Kyoto","author":"H Bartells","year":"1976","unstructured":"Bartells, H., Brener, K., Brittinger, G., Burger, A., Druhmke, E., Gunzer, U., Konig, E., Stacher, A., Theml, H., Waldner, R.: Clinical significance of the Kiehl classification of the Non- Hodgkin\u2019s lymphomas. Abstract S-19\u20135, p. 60. In: Abstracts of the 16th International Congress of Haematol., Kyoto, 1976"},{"key":"23_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-642-66639-1_4","volume-title":"Immunological Diagnosis of Leukemias and Lymphomas","author":"D Belpomme","year":"1977","unstructured":"Belpomme, D., Lelarge, N., Math\u00e9, G., Davies, A. J. S.: Etiological clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non- Hodgkin\u2019s lymphomas, pp. 33\u201345. In: \u201cImmunological Diagnosis of Leukemias and Lymphomas\u201d (Thierfelder, S., Rodt, H., Thiel, E. eds.) Heidelberg, New York: Springer, 1977"},{"key":"23_CR3","first-page":"28","volume-title":"\u201cLymphoid Neoplasias II\u201d (RRCR)","author":"D Belpomme","year":"1978","unstructured":"Belpomme, D., Caillou, B., Lelarge, N., Botto, I., Gerard-Marchant, A., Rappaport, H., Davies, A. J. S., Math\u00e9, G.: Prognostic value and clinical significance of the T-B-\u201cnull\u201d immunological classification of non-Hodgkin\u2019s lymphomas: its correlation with other classifications. In: \u201cLymphoid Neoplasias II\u201d (RRCR) (MATH\u00c9, G., Seligmann, M., Tubiana, M. eds.), pp. 28\u201340. Berlin- Heidelberg-New York: Springer, 1978"},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N","volume":"31","author":"RH Blum","year":"1973","unstructured":"Blum, R. H., Carter, S. K., Agre, K.: A clinical review of bleomycin, an antineoplastic agent. Cancer, 31, 309 (1973)","journal-title":"Cancer"},{"issue":"4","key":"23_CR5","first-page":"35","volume":"3","author":"SK Carter","year":"1973","unstructured":"Carter, S. K.: An overview of the status of the nitrosoureas in other tumours. Cancer Chemother. Rep., Part 3, 4, 35 (1973)","journal-title":"Rep., Part"},{"key":"23_CR6","volume-title":"Adriamycin","year":"1972","unstructured":"Carter, S. K., DI Marco, A., Ghione, M., Krakoff, I. H., MATH\u00c9, G. (eds.): Adriamycin. Berlin-Heidelberg-New York: Springer, 1972"},{"key":"23_CR7","volume-title":"RRCR","author":"A Clarysse","year":"1976","unstructured":"Clarysse, A., Kenis, Y., Math\u00e9, G.: Cancer chemotherapy (its role in the treatment strategy of hematologic malignancies and solid tumors). In: RRCR, Berlin-Heidelberg-New York: Springer, 1976, Vol. 53"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(75)91142-3","volume":"1","author":"VT Vita De","year":"1975","unstructured":"De Vita, V. T., Canellos, G. P., Chabner, B. A., Schein, P., Hubbard, S. P., Young, R. C.: Advanced histiocytic lymphoma, a potentially curable disease: Results with combination chemotherapy. Lancet, 1, 248\u2013250 (1975)","journal-title":"Lancet"},{"key":"23_CR9","first-page":"7","volume":"61","author":"TJ Garret","year":"1977","unstructured":"Garret, T. J., Gee, T. S., Dowling, M. D., Lee, B. J., Middleman, M. P., Clarkson, B. D., Young, C. W.: Cyclophosphamide L2 Protocol: A combination chemotherapeutic regimen for advanced non- Hodgkin\u2019s lymphomas, Cancer Treat. Rep., 61, 7\u201316 (1977)","journal-title":"Cancer Treat. Rep."},{"key":"23_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mpo.2950030107","volume":"3","author":"NC Gorin","year":"1977","unstructured":"Gorin, N. C., David, R., Stachowiak, J., Najman, A., Duhamel, G.: Combination of cyclophosphamide, vincristine and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with Non-Hodgkin\n\u2019s lymphomas. Med. Pediatr. Oncol., 3, 41\u201351 (1977)","journal-title":"Med. Pediatr. Oncol."},{"key":"23_CR11","doi-asserted-by":"crossref","unstructured":"Lennert, K., Mohri, N., Stein, H., Kaiserling, E.: The histopathology of malignant lymphoma. Brit. J. Haematol., 31, Suppl. 193 (1975)","DOI":"10.1111\/j.1365-2141.1975.tb00911.x"},{"key":"23_CR12","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-1378-6","volume-title":"Single Agents in Cancer Chemotherapy","author":"RB Livingston","year":"1970","unstructured":"Livingston, R. B., Carter, S. K.: Single Agents in Cancer Chemotherapy. New York: Plenum Press 1970"},{"key":"23_CR13","volume-title":"RRCR","author":"G Math\u00e9","year":"1976","unstructured":"Math\u00e9, G.: Cancer active immunotherapy, immunoprophylaxis and immunorestoration. An introduction. In: RRCR, Berlin-Heidelberg-New York: Springer, 1976, Vol. 55"},{"key":"23_CR14","first-page":"285","volume":"21","author":"G Math\u00e9","year":"1976","unstructured":"Math\u00e9, G., Belpomme, D., Dantchev, D.: Les h\u00e9matosarcomes non-hodgkiniens (classification du Centre de R\u00e9f\u00e9rence de l\u2019O.M.S.) Ann. Anat. Pathol., 21, 285\u2013300 (1976)","journal-title":"Ann. Anat. Pathol."},{"key":"23_CR15","first-page":"473","volume":"22","author":"G Math\u00e9","year":"1975","unstructured":"Math\u00e9, G., Belpomme, D., Dantchev, D., Khalil, A., Afifi, A. M., Taleb, N., Pouillart, P., SCHWARZENBERG, Hayat, M., De Vassal, F., Jasmin, C., Missett, J. L., Musset, M.: Immunoblastic lymphosarcoma, a cytological and clinical entity? Biomedicine, 22, 473\u2013488 (1975)","journal-title":"Immunoblastic lymphosarcoma, a cytological and clinical entity? Biomedicine"},{"key":"23_CR16","first-page":"177","volume":"22","author":"G Math\u00e9","year":"1975","unstructured":"Math\u00e9, G., Belpomme, D., Dantchev, D., Pouillart, P.: Progress in the classification of lymphoid and\/or monocytoid leukemias and or lympho- and reticulosarcomas. Biomedicine, 22, 177\u2013185 (1975)","journal-title":"Biomedicine"},{"key":"23_CR17","volume-title":"Integration of modern data in W.H.O. categorisation of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis","author":"G Math\u00e9","year":"1977","unstructured":"MATH\u00c9, G., Belpomme, D., Misset, J. L.: Integration of modern data in W.H.O. categorisation of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosis. Biomedicine, 1977. (In press)"},{"key":"23_CR18","unstructured":"Math\u00e9, G. and Kenis, Y.: La Chimioth\u00e9rapie des Cancers (Leuc\u00e9mies, H\u00e9matosarcomes et Tumeurs Solides). 3\u00e8me ed., Paris. Expansion Scientifique Fran\u00e7aise, 1975, 1 vol."},{"key":"23_CR19","unstructured":"Math\u00e9, G., Rappaport, H., O\u2019Conor, G. T., Torloni, H.: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. Geneva: W.H.O., 1976"},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/1097-0142(197410)34:4<985::AID-CNCR2820340402>3.0.CO;2-U","volume":"34","author":"G Math\u00e9","year":"1974","unstructured":"Math\u00e9, G., Schwarzenberg, L., Pouillart, P., Oldham, R., Weiner, R., Jasmin, C., Rosenfeld, C., Hayat, M., Misset, J. L., Musset, M., Schneider, M., Amiel, J. L., De Vassal, F.: Two epipodophyllotoxin derivatives VM26 and VP 16213, in the treatment of leukemias, hematosarcomas and lymphomas. Cancer, 34, 985\u2013992 (1974)","journal-title":"Cancer"},{"key":"23_CR21","first-page":"3117","volume":"4","author":"JL Misset","year":"1975","unstructured":"Misset, J. L., Pouillart, P., Amiel, J. L., Schwarzenberg, L., Hayat, M., De Vassal, F., Misset, M., Belpomme, D., Jasmin, C., Albahary, C., Depierre, R., Math\u00e9, G.: Combinaisond\u2019adrimaycine, de VM26, de cyclophosphamide et de prednisone (AVmCP) pour la chimioth\u00e9rapie des lymphor\u00e9ti- culosarcomes diss\u00e9min\u00e9s (Stades ou formes topographiques III et IV). Nouv. Presse. M\u00e9d., 4, 3117\u20133120(1975)","journal-title":"Nouv. Presse. M\u00e9d"},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mpo.2950030110","volume":"3","author":"S Monfardini","year":"1977","unstructured":"Monfardini, S., Tancini, G., De Lena, M., Villa, E., Valagussa, P., Bonadonna, G.: Cyclophosphamide, vincristine, and prednisone (C VP) versus adriamycin, bleomycine, and prednisone (ABP) in stage IV non-Hodgkin\u2019s lymphomas. Med. Pediatr. Oncol., 3, 67\u201374 (1977)","journal-title":"Med. Pediatr. Oncol."},{"key":"23_CR23","first-page":"65","volume":"61","author":"MJ O\u2019Connell","year":"1977","unstructured":"O\u2019Connell, M. J., Silverstein, M. N., Kiely, J. M., White, W. L.: Pilot study of two adriamycin- based regimens in patients with advanced malignant lymphomas. Cancer Treat. Rep., 61, 65\u201368 (1977)","journal-title":"Cancer Treat. Rep."},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/1097-0142(197603)37:3<1275::AID-CNCR2820370307>3.0.CO;2-M","volume":"37","author":"CS Portlock","year":"1976","unstructured":"Portlock, C. S., Rosenberg, S. A.: Combination chemotherapy with cyclophosphamide, vincristine and prednisone in advanced non-Hodgkin\u2019s lymphomas. Cancer, 37,1275\u20131282 (1976)","journal-title":"Cancer"},{"key":"23_CR25","first-page":"91","volume-title":"Tumours of the hematopoietic system","author":"H Rappaport","year":"1966","unstructured":"Rappaport, H.: Tumours of the hematopoietic system. Washington D. C., Armed Forces Institutes of Pathology, 1966, pp. 91\u2013206"},{"key":"23_CR26","first-page":"1","volume":"35","author":"HE Skipper","year":"1964","unstructured":"Skipper, H. E., Schabel, F. M., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with \u201ccurability\u201d of experimental leukemia. Cancer Chemother. Rep., 35, 1\u2013111 (1964)","journal-title":"Cancer Chemother. Rep."},{"key":"23_CR27","first-page":"5","volume":"45","author":"HE Skipper","year":"1965","unstructured":"Skipper, H. E., Schabel, F. M., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic concepts underlying chemotherapy of leukemia. Cancer Chemother. Rep. 45, 5\u201328 (1965)","journal-title":"Cancer Chemother. Rep"},{"key":"23_CR28","first-page":"125","volume":"51","author":"HE Skipper","year":"1967","unstructured":"Skipper, H. E., Schabel, F. M., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukaemic cells. Cancer Chemother. Rep., 51, 125\u2013165 (1967)","journal-title":"Cancer Chemother. Rep."},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1084\/jem.141.4.804","volume":"141","author":"RM Steinman","year":"1975","unstructured":"Steinman, R. M., Adams, J. C., Cohn, Z. A.: Identification of novel cell type in peripheral lymphoid organs of mice. III. Identification and distribution in mouse spleen. J. Exp. Med., 141, 808, 1975","journal-title":"J. Exp. Med."},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","volume":"137","author":"RM Steinman","year":"1973","unstructured":"Steinman, R. M., Cohn, Z. A.: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantification, tissue distribution. J. Exp. Med., 137, 1142 (1973)","journal-title":"J. Exp. Med."},{"key":"23_CR31","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1084\/jem.139.6.1431","volume":"139","author":"RM Steinman","year":"1974","unstructured":"Steinman. R. M., Lustig, D. S., Cohn, Z. A.: Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vivo. J. Exp. Med., 139, 1431 (1974)","journal-title":"J. Exp. Med."},{"key":"23_CR32","first-page":"845","volume":"48","author":"R Furth Van","year":"1972","unstructured":"Van Furth, R., Cohn, Z. A., Hirsch, J. G., Humphrey, J. H., Spector, W. G., Langevoort, H. L.: The mononuclear phagocyte system: a new classification of macrophages, monocytes and their precursor cells. Bull. W.H.O., 48, 845\u2013852 (1972)z","journal-title":"Bull. W.H.O"}],"container-title":["Recent Results in Cancer Research","Lymphoid Neoplasias II"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81249-1_23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T13:08:38Z","timestamp":1606396118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-81249-1_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978]]},"ISBN":["9783642812514","9783642812491"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81249-1_23","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-81249-1","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[1978]]}}}